Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility

Blood

Volumn 114, Issue 14, 2009, Pages 2952-2960

  Zhang, Ke ^a   Kagan, Daniel ^a   DuBois, Wendy ^a   Robinson, Richard ^a   Bliskovsky, Valery ^a   Vass, William C ^a   Zhang, Shuling ^a   Mock, Beverly A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PRISTANE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL GROWTH; DISEASE PREDISPOSITION; GENE CLUSTER; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOME; GRANULOMATOUS INFLAMMATION; HETEROZYGOTE; MOUSE; MOUSE STRAIN; MYELOID NUCLEAR DIFFERENTIATION ANTIGEN LIKE GENE; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; SCREENING; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CLONING, MOLECULAR; COLONY-FORMING UNITS ASSAY; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; HUMANS; INTERFERONS; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; NIH 3T3 CELLS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMACYTOMA; POLYMORPHISM, GENETIC; PROTEINS; TRANSCRIPTION FACTORS;

EID: 70449466603     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-01-198812     Document Type: Article

References (40)

1. Mock BA, Krall MM, Dosik JK. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc Natl Acad Sci U S A. 1993;90(20):9499-9503.
2. Sjogren B, Larsson P, Wang Z, Carlsson H, Grimvall E. Ingestion of herring leads to absorption of pristane in humans [letter]. Occup Environ Med. 1997;54(1):66.
3. Lee PY, Kumagai Y, Li Y, et al. TLR7-dependent and Fc{gamma}R-independent production of type I interferon in experimental mouse lupus. J Exp Med. 2008;205(13):2995-3006.
4. Potter M. Immunoglobulin-producing tumors and myeloma proteins of mice. Physiol Rev. 1972;52(3):631-719.
5. Potter M, Wax JS. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens. J Natl Cancer Inst. 1983;71(2):391-395.
6. Morse HC 3rd, Hartley JW, Potter M. Genetic considerations in plasmacytomas of BALB/c, NZB, and (BALB/c x NZB)F1 mice. In: Potter M, ed. Progress in Myeloma. Amsterdam, The Netherlands: Elsevier North Holland Inc;1980:263-279.
7. Morse HC 3rd Riblet R, Asofsky R, Weigert M. Plasmacytomas of the NZB mouse. J Immunol. 1978;121(5):1969-1972.
8. Mock BA, Hartley J, Le Tissier P, Wax JS, Potter M. The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4. Blood. 1997;90(10):4092-4098.
9. Bliskovsky V, Ramsay ES, Scott J, et al. Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. Proc Natl Acad Sci U S A. 2003;100(25):14982-14987.
10. Zhang S, Ramsay ES, Mock BA. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc Natl Acad Sci U S A. 1998;95(5):2429-2434.
11. Zhang SL, DuBois W, Ramsay ES, et al. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. Mol Cell Biol. 2001;21(1):310-318.
12. Rozzo SJ, Allard JD, Choubey D, et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity. 2001;15(3):435-443.
13. Alimirah F, Chen J, Davis FJ, Choubey D. IFI16 in human prostate cancer. Mol Cancer Res. 2007;5(3):251-259.
14. Chen IF, Ou-Yang F, Hung JY, et al. AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model. Mol Cancer Ther. 2006;5(1):1-7.
15. Woerner SM, Kloor M, Schwitalle Y, et al. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers. Genes Chromosomes Cancer. 2007;46(12):1080-1089.
16. Asefa B, Dermott JM, Kaldis P, Stefanisko K, Garfinkel DJ, Keller JR. p205, a potential tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation. FEBS Lett. 2006;580(5):1205hyphen]1214.
17. National Center for Biotechnology Information. EST: Expressed Sequence Tags database. http://ncbi.nlm.nih/gov/sites/entrez?dbnucest. Accessed June 2, 2006.
18. Luckey CJ, Bhattacharya D, Goldrath AW, Weissman IL, Benoist C, Mathis D. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Natl Acad Sci U S A. 2006;103(9):3304-3309.
19. Carrasco DR, Sukhdeo K, Protopopova M, et al. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell. 2007;11(4):349-360.
20. Asefa B, Klarmann KD, Copeland NG, Gilbert DJ, Jenkins NA, Keller JR. The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis. 2004;32(1):155-167.
21. Chang WL, Coro ES, Rau FC, Xiao Y, Erle DJ, Baumgarth N. Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J Immunol. 2007;178(3):1457-1467.
22. DeYoung KL, Ray ME, Su YA, et al. Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene. 1997;15(4):453-457.
23. Ding Y, Lee JF, Lu H, Lee MH, Yan DH. Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2. Mol Cell Biol. 2006;26(5):1979-1996.
24. Ludlow LE, Hii LL, Thorpe J, et al. Cloning and characterisation of Ifi206: a new murine HIN-200 family member. J Cell Biochem. 2008;103(4):1270- 1282.
25. Deschamps S, Meyer J, Chatterjee G, Wang H, Lengyel P, Roe BA. The mouse Ifi200 gene cluster: genomic sequence, analysis, and comparison with the human HIN-200 gene cluster. Genomics. 2003;82(1):34-46.
26. Ouchi M, Ouchi T. Role of IFI16 in DNA damage and checkpoint. Front Biosci. 2008;13:236-239.
27. Yalcin B, Dogan M, Buyukcelik A, Doruk H, Tek I, Demirkazik A. Interferon-alpha as maintenance therapy in patients with multiple myeloma[letter]. Ann Oncol. 2005;16(12):1981.
28. Geng Y, Choubey D. Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha. J Biol Regul Homeost Agents. 2000;14(4):263-268.
29. Joshi AD, Hegde GV, Dickinson JD, et al. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Clin Cancer Res. 2007;13(18, Pt1):5295-5304.
30. Nacionales DC, Kelly KM, Lee PY, et al. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14- tetramethylpentadecane (pristane). Am J Pathol. 2006;168(4):1227-1240.
31. Lee PY, Weinstein JS, Nacionales DC, et al. A novel type I IFN-producing cell subset in murine lupus. J Immunol. 2008;180(7):5101-5108.
32. Shiina T, Ando A, Suto Y, et al. Genomic anatomy of a premier major histocompatibility complex paralogous region on chromosome 1q21-q22. Genome Res. 2001;11(5):789-802.
33. Ludlow LE, Johnstone RW, Clarke CJ. The HIN-200 family: more than interferon-inducible genes? Exp Cell Res. 2005;308(1):1-17.
34. Bygrave AE, Rose KL, Cortes-Hernandez J, et al. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2004;2(8):E243.
35. Carlucci F, Cortes-Hernandez J, Fossati-Jimack L, et al. Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 Loci when expressed on C57BL/6 mice. J Immunol. 2007;178(4):2352-2360.
36. Choubey D, Deka R, Ho S-m. Interferon-inducible IFI16 protein in human cancers and autoimmune diseases. Front Biosci. 2008;13:598-608.
37. Heidari Y, Bygrave AE, Rigby RJ, et al. Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Genes Immun. 2006;7(7):592-599.
38. Choubey D, Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett. 2008;119(1-2):32-41.
39. Panchanathan R, Xin H, Choubey D. Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupusprone mice. J Immunol. 2008;180(9):5927-5934.
40. Xin H, Pramanik R, Choubey D. Retinoblastoma (Rb) protein upregulates expression of the Ifi202 gene encoding an interferon-inducible negative regulator of cell growth. Oncogene. 2003;22(31):4775-4785.